Number of CKD cases and prevalence per 100,000 population. by Achyut Raj Pandey (4102903)

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

“…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …”

Results on the trimmed datasets with a decreasing number of papers per author available for training and testing. by Leonard Bauersfeld (16475015)

Number of cases and prevalence of specific CKD per 100,000 population in 2019. by Achyut Raj Pandey (4102903)

DALYs due to CKD per 100,000 and proportion of DALYs attributable to CKD. by Achyut Raj Pandey (4102903)

Number of deaths, CKD Mortality rate per 100,000 and proportion of deaths attributable to CKD. by Achyut Raj Pandey (4102903)

MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

DALYs due to specific CKD conditions. by Achyut Raj Pandey (4102903)

“…Age-standardized prevalence rate of CKD increased from 5,979.1 cases per 100,000 population (95% UI: 5539.7, 6400.4) in 1990 to 7,634.1 cases per 100,000 population (95% UI: 7138.8, 8119.4) in 2019 with higher prevalence in males. …”

Mortality from specific CKD conditions. by Achyut Raj Pandey (4102903)

“…Age-standardized prevalence rate of CKD increased from 5,979.1 cases per 100,000 population (95% UI: 5539.7, 6400.4) in 1990 to 7,634.1 cases per 100,000 population (95% UI: 7138.8, 8119.4) in 2019 with higher prevalence in males. …”

Expected number of cases per year, CKD stage and scenario. by Magdalena Walbaum (11408576)

Expected number of cases and costs per year and CKD stage. by Magdalena Walbaum (11408576)

Number of deaths attributable to different risk factors ofCKD in 2019. by Achyut Raj Pandey (4102903)

Age-specific prevalence, death rate and DALYs due to CKD in 2019. by Achyut Raj Pandey (4102903)

Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

YLDs and YLLs per 100,000 due to CKD from 1990 to 2019. by Achyut Raj Pandey (4102903)

Increment function of COVID-19 confirmed cases. by Yessika Adelwin Natalia (12152177)

Effect of demographic parameters on ascribed aetiology of CKD. by Yusuf Urade (18404654)

Spread of COVID-19 (difference in cases, rate increase, incremental rate increase, and transmission rate β by province). by Alessandra Buja (535536)

“…<p>Spread of COVID-19 (difference in cases, rate increase, incremental rate increase, and transmission rate β by province).…”

Reduced contact tracing efficiency with increasing cases leads to accelerating epidemics. by Billy J. Gardner (10988034)

Subjects:

Characteristics and CKD incidence of 8 groups. by Yuriko Ono (2617635)

“…</p><p>Conclusions</p><p>This study establishes MASLD as a significant risk factor for CKD onset. Effective identification and management of MASLD cases are essential to mitigate the incidence of CKD.…”